Please use this identifier to cite or link to this item:
http://111.93.178.142:25000/jspui/handle/123456789/3536Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Bhagyashri Joshi, Padma V. Devarajan | - |
| dc.date.accessioned | 2026-05-01T07:16:20Z | - |
| dc.date.available | 2026-05-01T07:16:20Z | - |
| dc.date.issued | 2026-05-01 | - |
| dc.identifier.uri | http://111.93.178.142:25000/jspui/handle/123456789/3536 | - |
| dc.description | Vol. 60, No.7, p70 | en_US |
| dc.language.iso | en | en_US |
| dc.subject | Deferoxamine mesylate | en_US |
| dc.subject | netilmicin sulphate | en_US |
| dc.subject | oral absorption | en_US |
| dc.subject | permeation enhancers | en_US |
| dc.subject | intestinal sac | en_US |
| dc.subject | zebrafish larva model | en_US |
| dc.title | Feasibility of zebrafish larva model as a viable substitute to rat non-everted sac model for permeation evaluation of BCS III drugs | en_US |
| dc.type | Other | en_US |
| Appears in Collections: | Vol60, No. 7, 2023 | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.